ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2231

Improving Compliance with Screening for Osteoporosis in Elderly Women

Asad Ullah1, Shaza Khalid 1, Nagadarshini Vinod 1, Asghar Marwat 1, Ali Hussain 1, Tom Simunich 1, Medha Joshi 1 and Lavanya Vuppu 1, 1Conemaugh Memorial Medical Center, Johnstown

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Dual energy x-ray absorptiometry (DEXA) and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: US Preventive Task Force (USPSTF) recommends screening for osteoporosis in women ≥ 65 years of age with dual-energy X-ray absorptiometry (DEXA) scan. There was inconsistent pattern of ordering DEXA scans for screening of osteoporosis at our internal medicine clinic (IMC) at Conemaugh Memorial Medical Center. The main aim of this study was to improve the compliance with screening for osteoporosis with DEXA scan at our IMC as per recommendations by USPSTF.

Methods:

  • This is a quasi-experimental study with a pre and post intervention observational periods.
  • Patients’ medical charts from IMC at Conemaugh Memorial Medical Center were reviewed before an intervention period during which residents and clinic staff were educated regarding the importance of screening for osteoporosis and role of DEXA scans.
  • Resident education sessions emphasizing the importance of screening for osteoporosis with DEXA scan were conducted twice a month for a period of 3 months. The need of DEXA screening in women ≥ 65 years, the correct interpretation of DEXA scans and the medication options for women diagnosed with osteoporosis or those with osteopenia who qualify for treatment were emphasized.
  • Post intervention data was collected by reviewing patients’ medical charts. Pre and post intervention data was compared to see if the above interventions resulted in improvement in compliance with screening for osteoporosis.

Results:

  • Data from our pre intervention phase showed that 72 women met criteria for osteoporosis screening. Based on our analysis, 32% (23/72) women appropriately received osteoporosis screening with DEXA scan.
  • Post intervention data revealed that 58% (134/229) of patients that qualified for screening received DEXA scans.
  • This observed 26% increase was statistically significant (P = .0002, z-test for significant difference between two independent proportions).

Conclusion: DEXA scans have been identified as the most sensitive screening test for osteoporosis. Based on the results of DEXA scans, patients can be started on medications like bisphosphonates which have been associated with a decreased incidence of fragility fractures. Our post intervention data has demonstrated a significant improvement in the osteoporosis screening practices of the IMC residents. The intervention measures used by us were simple, proved to be effective, and can be readily implemented in other primary care settings.


Disclosure: A. Ullah, None; S. Khalid, None; N. Vinod, None; A. Marwat, None; A. Hussain, None; T. Simunich, None; M. Joshi, None; L. Vuppu, None.

To cite this abstract in AMA style:

Ullah A, Khalid S, Vinod N, Marwat A, Hussain A, Simunich T, Joshi M, Vuppu L. Improving Compliance with Screening for Osteoporosis in Elderly Women [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improving-compliance-with-screening-for-osteoporosis-in-elderly-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-compliance-with-screening-for-osteoporosis-in-elderly-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology